NRG ONCOLOGY/RTOG 0424: LONG-TERM RESULTS OF A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH-RISK LOW-GRADE GLIOMAS Conference

Fisher, Barbara, Zhang, Peixin, Macdonald, David et al. (2018). NRG ONCOLOGY/RTOG 0424: LONG-TERM RESULTS OF A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH-RISK LOW-GRADE GLIOMAS . NEURO-ONCOLOGY, 20 11-11.

International Collaboration

cited authors

  • Fisher, Barbara; Zhang, Peixin; Macdonald, David; Chakravarti, Arnab; Lesser, Glenn; Fox, Sherry; Coons, Stephen; Rogers, Leland; Werner-Wasik, Maria; Doyle, Thomas; Bahary, Jean-Paul; Fiveash, John; Bovi, Joseph; Howard, Steven; Yu, Michael; Dsouza, David; Laack, Nadia; Roach, Mack; Kwok, Young; Wahl, Daniel; Stasser, John; Won, Minhee; Mehta, Minesh P

sustainable development goals

authors

date/time interval

  • November 14, 2018 -

publication date

  • November 1, 2018

webpage

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • New Orleans, LA

Conference

  • 23rd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO) / 3rd CNS Anticancer Drug Discovery and Development Conference

publisher

  • OXFORD UNIV PRESS INC

start page

  • 11

end page

  • 11

volume

  • 20